|
|
Volumn 31, Issue 1-2, 1999, Pages 80-81
|
|
Effects of continuous, long-term therapy with prostaglandin E1 preoperatively on outcome after heart transplantation
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CARDIAC AGENT;
CYCLOSPORIN;
IMMUNOSUPPRESSIVE AGENT;
INOTROPIC AGENT;
PROSTAGLANDIN E1;
STEROID;
ADULT;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTINUOUS INFUSION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
FORWARD HEART FAILURE;
GRAFT REJECTION;
HEART FAILURE;
HEART LEFT VENTRICLE FILLING PRESSURE;
HEART TRANSPLANTATION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAVENOUS DRUG ADMINISTRATION;
LONG TERM CARE;
LUNG CONGESTION;
MAJOR CLINICAL STUDY;
MALE;
ORAL DRUG ADMINISTRATION;
PREOPERATIVE TREATMENT;
PRIORITY JOURNAL;
SURVIVAL;
TREATMENT OUTCOME;
ALPROSTADIL;
CARDIOTONIC AGENTS;
DOBUTAMINE;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FIBRINOLYTIC AGENTS;
GRAFT REJECTION;
HEART TRANSPLANTATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
MIDDLE AGED;
MORBIDITY;
POSTOPERATIVE COMPLICATIONS;
RETROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
TIME FACTORS;
|
|
EID: 0033024145
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)01446-8 Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (3)
|
